Lilly Canada Sponsors Innovation Challenge Amid Warnings Over Drug Access Barriers
What happened
Lilly Canada sponsored a Health Innovation Challenge, an event held on October 23. During the event, HealthCareCAN highlighted significant barriers to accessing medical breakthroughs in Canada. Michelle McLean, president and CEO of HealthCareCAN, stated that Canadians currently have access to only 18 percent of medications available globally, and the country ranks last in the G7 for timely access to medications.
From theglobeandmail.com
Why it matters
The challenge underscores systemic issues in Canada's healthcare structure, which is described as overworked and lacking capacity to keep pace with medical innovation. This context exists while the UN has determined that Canada is not contributing fairly to innovation, and drug approvals are handled by Health Canada while US policy stalls launches.
The UN determined that Canada is not contributing fairly to innovation, while Health Canada handles drug approvals and US policy stalls launches.
From theglobeandmail.com
Who's involved
- Eli Lilly and CompanySponsor of the Health Innovation Challenge
- HealthCareCANNational organization that warned about Canadian access barriers